Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Generex Biotechnology Corp. (GNBTQ : OTC)

• Company Description    Generex Biotechnology Corporation provides research, development, and commercialization of drug delivery systems and technologies. The company's products include Generex Oral-lyn, Glucose RapidSpray, BaBOOM Energy Spray and Crave-NX. It markets its products primarily in Ecuador, Canada, and the United States. Generex Biotechnology Corporation is based in Toronto, Canada. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $ Daily Weekly Monthly 20 Day Moving Average: shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 52 Week High: $0.00 52 Week Low: $0.00 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week % % 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10102 USA TODAY WAY - MIRAMAR,FL 33025 USA ph: 416-364-2551 fax: 64-7547-7104 info@generex.com http://generex.com/index.html

• General Corporate Information    Officers Joseph Moscato - President and Chief Executive Officer Terry Thompson - Chief Operating Officer Mark Corrao - Chief Financial Officer; Treasurer Andrew Ro - Chief Investment Officer; Director Lawrence Salvo - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 371485301 SIC: 2834 Fiscal Year Fiscal Year End: July Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: Most Recent Split Date: 2.00 (1.40:1) Beta: Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: % Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 04/30/25 - - 01/31/25 - - 10/31/24 - - ROA 04/30/25 - - 01/31/25 - - 10/31/24 - - Current Ratio 04/30/25 - - 01/31/25 - - 10/31/24 - - Quick Ratio 04/30/25 - - 01/31/25 - - 10/31/24 - - Operating Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Net Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Pre-Tax Margin 04/30/25 - - 01/31/25 - - 10/31/24 - - Book Value 04/30/25 - - 01/31/25 - - 10/31/24 - - Inventory Turnover 04/30/25 - - 01/31/25 - - 10/31/24 - - Debt-to-Equity 04/30/25 - - 01/31/25 - - 10/31/24 - - Debt-to-Capital 04/30/25 - - 01/31/25 - - 10/31/24 - -

Powered by Zacks Investment Research ©